In the News

It sounds like science fiction: people with end-stage liver disease are injected with cells from a donor liver and, in response, their body produces multiple mini livers that keep them healthy. Yet,...

Jim Mellon, Juvenescence Chairman, explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns. “There’s a lot of great stuff happening, but it’s not...

A series of upcoming studies will explore whether the grind of active-duty military life and veterans’ disproportionately high incidence of chronic illness could be tamed by lifestyle interventions designed to...

LyGenesis hopes to save people with devastating liver diseases who are not eligible for transplants. Their approach is to inject liver cells from a donor into the lymph nodes of...

Longevity Technology sits down with Chrysea CEO, Pedro de Noronha Pissarra to talk about the company, its raise and its IP.

Dr. Greg Bailey, MD, CEO of Juvenescence discusses innovations in the longevity space in this interview with host James Ruhle of ‘The Simple BioTech Podcast’.

Master Investor is one of the leading investor meetings. Our CEO and co-founder gives his views on the future of longevity science, investments that will fund progress, and Juvenescence's role...

Juvenescence’s new breakthrough C6 Ketone Di-ester product, a GRAS (Generally Recognized as Safe) ingredient, was highlighted in Longevity Technology’s inaugural report, “A new era of healthspan and longevity: Longevity supplements.”...

Our partner, the Buck Institute for Research on Aging launched an investigational study on ketones to ascertain how they may support aging. “This is a landmark event at the Buck Institute. It’s...

Dr Brianna Stubbs discusses ketosis research and a new webinar that features leading experts in the ketone metabolism research field.

Juvenescence partnered with Shape to produce this guide to ketosis. Learn how best to tweak your ketosis to impact results.

Juvenescence co-founder Jim Mellon gives his perspective on how advances in extending human life will impact the world economy and healthcare systems.